CARDIOL THERAPEUTICS INC-A (CRDL) Stock Cash Flow
NASDAQ:CRDL - Nasdaq - CA14161Y2006 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -35.79M | -36.68M | -28.13M | -30.93M | -31.64M | |||
| Depreciation Amortization | 336.50K | 373.10K | 248.40K | 220.00K | 220.00K | |||
| Change In Working Capital | -1.05M | -931.60K | -545.90K | 5.75M | 80.00K | |||
| Other non cash items | 11.21M | 12.17M | 3.25M | -2.26M | 7.79M | |||
| OPERATING CASH FLOW | -25.29M | -25.06M | -25.18M | -27.22M | -23.55M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -29.70K | -21.30K | -64.30K | -70.00K | -10.00K | |||
| INVESTING CASH FLOW | -29.70K | -21.30K | -64.30K | -70.00K | -10.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -41.50K | -41.50K | -55.40K | -50.00K | -50.00K | |||
| Stock Issued/Repurchased | 21.44M | 21.53M | N/A | 0.00 | 98.73M | |||
| Other Financing Activity | N/A | -2.65M | N/A | 0.00 | -5.24M | |||
| FINANCING CASH FLOW | 18.75M | 18.84M | -55.40K | -50.00K | 93.44M | |||
| Exchange Rate Effect | 1.29M | 1.89M | 762.00K | 2.92M | N/A | |||
| CHANGE IN CASH | -5.28M | -4.35M | -24.54M | -24.42M | 69.88M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -25.29M | -25.06M | -25.18M | -27.22M | -23.55M | |||
| Capital Expenditure | -29.70K | -21.30K | -64.30K | -70.00K | -10.00K | |||
| FREE CASH FLOW | -25.32M | -25.08M | -25.24M | -27.29M | -23.56M | |||
All data in CAD